YONGHE MED.GR.DL-0000025 (L97) — Cash Flow Reinvestment Rate
YONGHE MED.GR.DL-0000025 (L97) has a Cash Flow Reinvestment Rate of 0.14x as of December 2025, reinvesting €68.90 Million (capex €18.90 Million plus investments €-50.00 Million) from operating cash flow of €495.53 Million. See YONGHE MED.GR.DL-0000025 (L97) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
YONGHE MED.GR.DL-0000025 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for YONGHE MED.GR.DL-0000025 across 3 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of YONGHE MED.GR.DL-0000025.
Annual Cash Flow Reinvestment Rate for YONGHE MED.GR.DL-0000025 (2021–2025)
Year-by-year capital reinvestment analysis for YONGHE MED.GR.DL-0000025. See financial agility of YONGHE MED.GR.DL-0000025 to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.14x | €68.90 Million | €495.53 Million | €18.90 Million | ▼ -40.9% |
| 2024 | 0.24x | €53.76 Million | €228.62 Million | €53.76 Million | ▼ -46.1% |
| 2021 | 0.44x | €190.64 Million | €437.28 Million | €190.64 Million | — |